Applications including "drug"

LT203 - Analysis of cyclosporin A in serum using MonoSpin C18 and Ph. -

LC Technical Note InertSustain Phenyl
LT201 - Analysis of nitrosoamines by LC-MS / MS, HPLC using InertSustain AQ-C18 -Comparison with PFP column- -

LC Technical Note InertSustain AQ-C18 InertSustain PFP
ST030 - Analysis of cyromazine in livestock products -

SPE Technical Note InertSustain C18
LB043 - Analysis of 18Drugs(InertSustain C18 HP) -

LC InertSearch InertSustain C18
LA908 - Analysis of 17 Anti-depressant drugs (InertSustain C18) -

LC InertSearch InertSustain C18
LB883 - Analysis of Paclitaxel -

LC InertSearch InertSustain PFP
LB837 - Analysis of Nonsteroidal anti-inflammatory drug -

LC InertSearch InertSustain C30
LB738 - Analysis of Remdesivir -

LC InertSearch InertSustain AX-C18
GA342 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GC InertSearch InertCap WAX
GA341 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GC InertSearch InertCap WAX
GA340 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GC InertSearch InertCap WAX
GA339 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GC InertSearch InertCap 624MS
GA338 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GC InertSearch InertCap 624MS
GA337 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GC InertSearch InertCap 624MS
LB698 - Analysis of Neomycin Sulfate (European Pharmacopoeia 11.0th Edition, Purity Test) -

LC InertSearch InertSustain C18
LB692 - Analysis of Nitrosamines -

LC InertSearch InertSustain AQ-C18
LB691 - Analysis of Nitrosamines -

LC InertSearch InertSustain PFP
GA333 - Residual solvents in pharmaceuticals (JP 18 Standard stock solution Class 2 C) -

GC InertSearch InertCap WAX
GA332 - Residual solvents in pharmaceuticals (JP 18 Standard stock solution Class 2 C) -

GC InertSearch InertCap 624MS
GA331 - Residual solvents in pharmaceuticals (JP 18 Standard stock solution Class 2 C) -

GC InertSearch InertCap 624MS
GA330 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GC InertSearch InertCap WAX
GA329 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GC InertSearch InertCap 624MS
GA328 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GC InertSearch InertCap 624MS
GA327 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GC InertSearch InertCap WAX
GA326 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GC InertSearch InertCap 624MS
GA325 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GC InertSearch InertCap 624MS
GA324 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GC InertSearch InertCap WAX
GA323 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GC InertSearch InertCap 624MS
GA322 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GC InertSearch InertCap 624MS
LB690 - Analysis of Nitrosamines -

LC InertSearch InertSustain PFP
LB676 - Analysis of Anticancer drug and related substances -

LC InertSearch InertSustain PFP HP
LB597 - Analysis of 11 Drugs -

LC InertSearch MonoSelect C18 for HTS
LT161 - Purification of Ribavirin in Human Serum Using MonoSpin PBA -

LC Technical Note InertSustain AQ‐C18 HP
LT159 - Assay Test for Esomeprazole Magnesium Delayed -Release Capsules under USP Method -

LC Technical Note InertSustain C18
LT096 - Analysis of Atorvastatin Calcium -

LC Technical Note Inertsil C8-4 Inertsil C8-4 HP
LT092 - Analysis of Tranexamic Acid According to the Japanese Pharmacopoeia -

LC Technical Note InertSustain AQ-C18 Inertsil ODS-4
LT080 - Analysis of Sennosides in Senna in Accordance with the Japanese Pharmacopoeia -

LC Technical Note Inertsil ODS-4
LT079 - Analysis of Melamine in Food by LC/MS/MS -

LC Technical Note Inertsil HILIC
LT052 - Analysis of Geniposide with a Photodiode Array Detection -

LC Technical Note Inertsil ODS-SP
LT044 - Analysis of Bufosteroids in Senso In Accordance with the Japanese Pharmacopoeia -

LC Technical Note Inertsil ODS-P
LT040 - Analysis of peony (Chinese paeoniflorin) in accordance with the 15th edition of the Japanese Pharmacopoeia -

LC Technical Note Inertsil ODS-3 Inertsil ODS-SP
LT039 - Analysis of Glycyrrhizic Acid in Licorice According to the Japanese Pharmacopoeia -

LC Technical Note
LT038 - Analysis of Scopolamine and Hyoscyamine in Scopolia Extract in Accordance with the Japanese Pharmacopoeia -

LC Technical Note Inertsil ODS-SP
LP001 - Direct, simultaneous measurement of liposome-encapsulated and released drugs in plasma by on-line SPE-SPE-HPLC
Journal of Chromatography B, Vol. 879, 3620-3625, (2011) -

LC InertSearch InertSustain C18
LB518 - Analysis of Glycyrrhetinic acid (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Monoammonium α-Glycyrrhizinate) -

LC InertSearch InertSustain C18
LB517 - Analysis of Glycyrrhizic acid (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Glycyrrhiza Extracted Powder) -

LC InertSearch InertSustain C18
LB516 - (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Coffee Extract) -

LC InertSearch InertSustain C18
LB515 - Analysis of Caffeine (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Coffee Extract) -

LC InertSearch InertSustain C18
LB510 - Analysis of Estradiol and Progesterone (Under the Condition of the draft for the Japanese Standards of Quasi-drug Ingredients, Placental Extract) -

LC InertSearch InertSustainSwift C18
LB423 - Analysis of Nonsteroidal anti-inflammatory drug （InertSustain Phenyl） -

LC InertSearch InertSustain Phenyl
LB422 - Analysis of Nonsteroidal anti-inflammatory drug （InertSustain C18） -

LC InertSearch InertSustain C18
LB421 - Analysis of Nonsteroidal anti-inflammatory drug （InertSustain Phenylhexyl） -

LC InertSearch InertSustain Phenylhexyl
LB400 - Analysis of 9 Drugs (InertSustain C18) -

LC InertSearch InertSustain C18
LB399 - Analysis of 9 Drugs (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB398 - Analysis of 9 Drugs (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB391 - Analysis of 12 Drugs (Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LB390 - Analysis of 12 Drugs (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB389 - Analysis of 12 Drugs (InertSustainSwift C18 HP) -

LC InertSearch InertSustainSwift C18 HP
LB388 - Analysis of 12 Drugs (InertSustain C18 HP) -

LC InertSearch InertSustain C18 HP
LB387 - Analysis of 12 Drugs (InertSustain AQ-C18 HP) -

LC InertSearch InertSustain AQ-C18 HP
LB276 - Analysis of Anti-depressant drugs -

LC InertSearch InertSustain Phenylhexyl
LB261 - Analysis of 18 Drugs -

LC InertSearch Inertsil ODS-3
LB198 - Analysis of Steroidal anti-inflammatory drug -

LC InertSearch InertSustain Phenyl
LB139 - Analysis of Nonsteroidal anti-inflammatory drug -

LC InertSearch InertSustain Phenyl
LB138 - Analysis of Steroidal anti-inflammatory drug -

LC InertSearch InertSustain Phenyl
LB070 - Analysis of 13 drugs for NSAIDs -

LC InertSearch InertSustain C18
LB042 - Analysis of 18Drugs(InertSustain C18 2um) -

LC InertSearch InertSustain C18
LA903 - Analysis of Basic drugs (InertSustain C18) -

LC InertSearch InertSustain C18
LA902 - Analysis of Basic drugs (InertSustain C18) -

LC InertSearch InertSustain C18
LA890 - Analysis of Basic Drugs (InertSustain C18) -

LC InertSearch InertSustain C18 HP
LA889 - Analysis of Basic Drugs (InertSustain C18) -

LC InertSearch InertSustain C18 HP
LA855 - Analysis of 17 Drugs -

LC InertSearch Inertsil ODS-4
LA854 - Analysis of 18 Drugs -

LC InertSearch Inertsil ODS-4
LA827 - Analysis of 4 drugs for animal (animal product III) -

LC InertSearch Inertsil ODS-4
LA820 - Analysis of 29 drugs for animal (animal product III) -

LC InertSearch Inertsil ODS-4
LA777 - Analysis of 4 Drugs -

LC InertSearch Inertsil ODS-3
LA761 - Analysis of 6 Sulfa drugs (III) -

LC InertSearch Inertsil Sulfa C18
LA760 - Analysis of 7 Sulfa drugs (II) -

LC InertSearch Inertsil Sulfa C18
LA759 - Analysis of 6 Sulfa drugs (I) -

LC InertSearch Inertsil Sulfa C18
LA758 - Analysis of 15 Sulfa drugs -

LC InertSearch Inertsil Sulfa C18
LA757 - Analysis of Drugs -

LC InertSearch Inertsil ODS
LA714 - Analysis of Drugs -

LC InertSearch Inertsil ODS-3
LA677 - Analysis of Crude Drugs -

LC InertSearch Inertsil ODS-4
LA610 - Analysis of Drugs by LC/MS/MS -

LC InertSearch Inertsil ODS-3
LA153 - Bilirubin in Crude drug -

LC InertSearch Inertsil ODS-3
LA144 - Sulphur drugs -

LC InertSearch Inertsil ODS-2
LA138 - Components of Cold-drugs -

LC InertSearch Inertsil ODS-2
LA028 - Drug -

LC InertSearch Inertsil ODS-3V
LA027 - Drug -

LC InertSearch Inertsil ODS-3V
GT083 - Purity Test of Calcium Polystyrene Sulfonate, with reference to the Japanese Pharmacopoeia, 16th Edition - Comparisons of Chromosorb Series and Uniport Series of Siliceous Soil Support -

GC Technical Note
GT054 - Purity Test of Epirubicin Hydrochloride with Reference to the Japanese Pharmacopoeia -

GC Technical Note InertCap WAX
GT035 - Analysis of Residual Solvent Components in Drugs - Using InertCap 624 -

GC Technical Note InertCap 624
GT023 - Analysis of Residual Solvent Components in Pharmaceutical Products ? Using InertCap Pure-WAX -

GC Technical Note InertCap Pure-WAX
GA166 - Purity test of Epirubicin Hydrochloride by Japanese pharmacopoeia -

GC InertSearch InertCap Pure-WAX
GA151 - Purity test of Acethexamide -

GC InertSearch InertCap 1
GA144 - Purity test of Epirubicin Hydrochloride -

GC InertSearch InertCap WAX

Applications including "drug"

LT203 - Analysis of cyclosporin A in serum using MonoSpin C18 and Ph. -

LT201 - Analysis of nitrosoamines by LC-MS / MS, HPLC using InertSustain AQ-C18 -Comparison with PFP column- -

ST030 - Analysis of cyromazine in livestock products -

LB043 - Analysis of 18Drugs(InertSustain C18 HP) -

LA908 - Analysis of 17 Anti-depressant drugs (InertSustain C18) -

LB883 - Analysis of Paclitaxel -

LB837 - Analysis of Nonsteroidal anti-inflammatory drug -

LB738 - Analysis of Remdesivir -

GA342 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GA341 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GA340 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GA339 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GA338 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GA337 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

LB698 - Analysis of Neomycin Sulfate (European Pharmacopoeia 11.0th Edition, Purity Test) -

LB692 - Analysis of Nitrosamines -

LB691 - Analysis of Nitrosamines -

GA333 - Residual solvents in pharmaceuticals (JP 18 Standard stock solution Class 2 C) -

GA332 - Residual solvents in pharmaceuticals (JP 18 Standard stock solution Class 2 C) -

GA331 - Residual solvents in pharmaceuticals (JP 18 Standard stock solution Class 2 C) -

GA330 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GA329 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GA328 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GA327 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GA326 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GA325 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GA324 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GA323 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GA322 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

LB690 - Analysis of Nitrosamines -

LB676 - Analysis of Anticancer drug and related substances -

LB597 - Analysis of 11 Drugs -

LT161 - Purification of Ribavirin in Human Serum Using MonoSpin PBA -

LT159 - Assay Test for Esomeprazole Magnesium Delayed -Release Capsules under USP Method -

LT096 - Analysis of Atorvastatin Calcium -

LT092 - Analysis of Tranexamic Acid According to the Japanese Pharmacopoeia -

LT080 - Analysis of Sennosides in Senna in Accordance with the Japanese Pharmacopoeia -

LT079 - Analysis of Melamine in Food by LC/MS/MS -

LT052 - Analysis of Geniposide with a Photodiode Array Detection -

LT044 - Analysis of Bufosteroids in Senso In Accordance with the Japanese Pharmacopoeia -

LT040 - Analysis of peony (Chinese paeoniflorin) in accordance with the 15th edition of the Japanese Pharmacopoeia -

LT039 - Analysis of Glycyrrhizic Acid in Licorice According to the Japanese Pharmacopoeia -

LT038 - Analysis of Scopolamine and Hyoscyamine in Scopolia Extract in Accordance with the Japanese Pharmacopoeia -

LP001 - Direct, simultaneous measurement of liposome-encapsulated and released drugs in plasma by on-line SPE-SPE-HPLCJournal of Chromatography B, Vol. 879, 3620-3625, (2011) -

LB518 - Analysis of Glycyrrhetinic acid (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Monoammonium α-Glycyrrhizinate) -

LB517 - Analysis of Glycyrrhizic acid (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Glycyrrhiza Extracted Powder) -

LB516 - (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Coffee Extract) -

LB515 - Analysis of Caffeine (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Coffee Extract) -

LB510 - Analysis of Estradiol and Progesterone (Under the Condition of the draft for the Japanese Standards of Quasi-drug Ingredients, Placental Extract) -

LB423 - Analysis of Nonsteroidal anti-inflammatory drug （InertSustain Phenyl） -

LB422 - Analysis of Nonsteroidal anti-inflammatory drug （InertSustain C18） -

LB421 - Analysis of Nonsteroidal anti-inflammatory drug （InertSustain Phenylhexyl） -

LB400 - Analysis of 9 Drugs (InertSustain C18) -

LB399 - Analysis of 9 Drugs (InertSustainSwift C18) -

LB398 - Analysis of 9 Drugs (InertSustain AQ-C18) -

LB391 - Analysis of 12 Drugs (Inertsil ODS-3) -

LB390 - Analysis of 12 Drugs (Inertsil ODS-4) -

LB389 - Analysis of 12 Drugs (InertSustainSwift C18 HP) -

LB388 - Analysis of 12 Drugs (InertSustain C18 HP) -

LB387 - Analysis of 12 Drugs (InertSustain AQ-C18 HP) -

LB276 - Analysis of Anti-depressant drugs -

LB261 - Analysis of 18 Drugs -

LB198 - Analysis of Steroidal anti-inflammatory drug -

LB139 - Analysis of Nonsteroidal anti-inflammatory drug -

LB138 - Analysis of Steroidal anti-inflammatory drug -

LB070 - Analysis of 13 drugs for NSAIDs -

LB042 - Analysis of 18Drugs(InertSustain C18 2um) -

LA903 - Analysis of Basic drugs (InertSustain C18) -

LA902 - Analysis of Basic drugs (InertSustain C18) -

LA890 - Analysis of Basic Drugs (InertSustain C18) -

LA889 - Analysis of Basic Drugs (InertSustain C18) -

LA855 - Analysis of 17 Drugs -

LA854 - Analysis of 18 Drugs -

LA827 - Analysis of 4 drugs for animal (animal product III) -

LA820 - Analysis of 29 drugs for animal (animal product III) -

LA777 - Analysis of 4 Drugs -

LA761 - Analysis of 6 Sulfa drugs (III) -

LA760 - Analysis of 7 Sulfa drugs (II) -

LA759 - Analysis of 6 Sulfa drugs (I) -

LP001 - Direct, simultaneous measurement of liposome-encapsulated and released drugs in plasma by on-line SPE-SPE-HPLC
Journal of Chromatography B, Vol. 879, 3620-3625, (2011) -